Below a specific threshold, FCP exerts a protective effect, but above that threshold the protective effect becomes uncertain.

As diabetes cases soar in the US, physicians are sounding the alarm, especially in economically challenged regions. The push ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Our findings raise the possibility of using PEPITEM derived peptides for the treatment of psoriasis ... use in therapies for ...

Birmingham scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis when applied ...

The study, led by Dr Luca Busetto from the University of Padova in Italy and colleagues from Eli Lilly and Company that ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic ...

Taking tirzepatide drug once a week may produce clinically meaningful and sustained weight loss for at least 3 years in ad ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

In patients with type 2 diabetes, the risk for chronic kidney disease differed among users of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylurea.